All News

Found 90 articles

• DJO® and SirenMD® Announce Partnership for Collaboration

  11/7/2018

  DJO®, a leading provider of medical technologies designed to get and keep people moving, announced the partnership with SirenMD, becoming the exclusive sales representative for SirenMD’s sports team market.

• DJO® Announces Industry-First Risk Assessment Tool To Confirm Outpatient Joint Replacement Pathways

  11/1/2018

  Risk stratification tool for Outpatient Total Joint Arthroplasty demonstrates improved predictive value for discharge to home, same day or next day

• DJO Global Announces Date for Release of Third Quarter 2018 Results

  11/1/2018

  DJO Global, Inc., a leading global provider of medical technologies designed to get and keep people moving, today announced the following information for the release of its third quarter 2018 financial results and a conference call to discuss those results.

• DJO® Unveils Two Additional Products, Further Expanding the Breadth of the EMPOWR Knee System®

  11/1/2018

  DJO, a leading provider of medical technologies designed to get and keep people moving, introduced the EMPOWR Porous™ Knee System and EMPOWR™ Complex Primary Knee System at the 2018 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) today (Booth # 510).

• Clinical Study Shows DJO’s “Dual-Pivot” Knee Replacement Technology Reduces Patient Dissatisfaction, Improves Function and Activity Levels

  10/23/2018

  DJO (“DJO” or the “Company”), a leading provider of medical technologies designed to get and keep people moving, released a new clinical study to show that EMPOWR 3D Knee technology reduces patient dissatisfaction, and improves function and activity levels

• DJO Global Announces Financial Results for Second Quarter 2018

  8/6/2018

  Strength of Business Transformation Efforts Continue to Drive Revenue, Profit Growth

• DJO Global Announces Date for Release of Second Quarter 2018 Results

  7/27/2018

  July 27, 2018 16:33 UTC DJO Global Announces Date for Release of Second Quarter 2018 Results SAN DIEGO--( BUSINESS WIRE )-- DJO Global, Inc., a leading global provider of medical technologies designed to get and keep people moving, today announced the following information for the release of its second quarter 2018 financial results and a conference call to discuss those results. Date: Monday, August 6, 2018

• DJO Global Announces Financial Results for Third Quarter 2017

  11/15/2017

  Net sales grew 1.3% to $290.9 million, or 0.3% at constant currency rates.

• Sarepta Therapeutics Announces FDA Clearance of IND for the Company’s PPMO Exon 51 Candidate, SRP-5051

  11/7/2017

  Sarepta to immediately initiate a Phase 1/2a clinical trial in patients with Duchenne muscular dystrophy (DMD) amenable to skipping exon 51.

• DJO Global Announces Date for Release of Third Quarter 2017 Results

  11/7/2017

  DJO Global, Inc., a leading global provider of medical technologies designed to get and keep people moving, today announced the following information for the release of its third quarter 2017 financial results and a conference call to discuss those results.

• DJO Global Release: Wear A Pink Exos Wrist Brace In October; Join The Fight Against Breast And Ovarian Cancer

  10/6/2017

• LiveLeaf‘s Novel Plant-Based Pro-Drug Platform Demonstrates Efficient Vitro Growth Inhibition Of All Multi-Drug Resistant ESKAPE Pathogens

  6/13/2017

• DJO Global Announces Appointment Of Jeffery Mccaulley As Global President, DJO Surgical

  5/30/2017

• DJO Global Announces Date For Release Of First Quarter 2017 Results

  5/4/2017

• Syntimmune Announces Breakthrough Results Of FcRn Inhibition Published In PNAS

  3/21/2017

• DJO Global Grabs FDA Nod for Exprt Revision Hip

  3/15/2017

• DJO Global Release: DonJoy Revolutionizes Osteoarthritis Bracing With Introduction Of "TriFit" Knee Brace

  3/15/2017

• DJO Global Announces The Launch Of The Altivate Anatomic Shoulder System

  3/13/2017

• DJO Global Announces Appointment Of Bryan McMillan As President, Regeneration

  3/2/2017

• DJO Global Announces Date For Release Of Fourth Quarter And Fiscal Year End 2016 Results

  2/22/2017